SELECT FROM MENU

Therapy Areas
Drug Classes

       Therapy Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Advanced NSCLC

Advanced NSCLC

SCLC

SCLC

Biomarkers

Biomarkers

       Drug Classes

Targeted Therapies

Targeted Therapies

Immunotherapies

Immunotherapies

ADCs

ADCs

Sandip Patel

Sandip Patel

UC San Diego Moores Cancer Center, La Jolla

Dr. Sandip P. Patel is a Professor of Medical Oncology at UC San Diego Moores Cancer Center in La Jolla, California, where he directs the Clinical Trials Office and co-leads the Experimental Therapeutics (Phase 1) Program. His work centers on early-phase cancer immunotherapy and thoracic oncology, including checkpoint-inhibitor and neoadjuvant immunotherapy strategies in non-small cell lung cancer, and he led the SWOG S1609 DART trial, the first NCI-funded rare-tumor immunotherapy basket study. He co-leads the NRG Developmental Therapeutics Committee and is a frequent speaker at major international oncology congresses.

Connect

Sandip Patel

Featured in